A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/05/2002	US20020183377 Use of melatonin for treating androgenetic and diffuse alopecia
12/05/2002	US20020183368 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma
12/05/2002	US20020183359 Ophthalmic composition
12/05/2002	US20020183347 For use in therapy of respiratory tract diseases
12/05/2002	US20020183345 Administering to a drug naive human patient in need of treatment, as first line therapy, a low dose of a combination of metformin and glyburide
12/05/2002	US20020183308 Benazepril Hydrochloride tablet formulations
12/05/2002	US20020183296 Applying a hydroalcoholic gel containing testosterone to skin of the male subject in an amount effective to treat the hypogonadism
12/05/2002	US20020183293 Administering durg comprising formoterol, or a derivative thereof and asteroidal anti-inflammatory agent, or a derivative in a pharmacologically suitable fluid, wherein the drug formulation is stable during long term storage
12/05/2002	US20020183292 For therapy of respiratory tract diseases
12/05/2002	US20020183282 For skin, muscle, ocular or gastric mucosal healing
12/05/2002	US20020183280 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye
12/05/2002	US20020183279 For therapy and prophylaxis of infections and inflammations associated with intraocular surgery and intra-articular injection
12/05/2002	US20020183278 For therapy and prophylaxis of painful ulcerative and inflammatory conditions of moist surfaces such as mouth, oropharynx, oesophagus, vagina and rectum (e.g., mucositis, stomatitis, aphthous ulcerations, and Behcet' syndrome)
12/05/2002	US20020183265 Manufacture and use of an antibiotic/antibiotics preparation
12/05/2002	US20020183261 Oral administration of these can stimulate proliferation of osteoblast, inhibit bone resorption and strengthen bone; can be useful for improvement of osteoporosis, bone fracture, bone pain, etc
12/05/2002	US20020183253 Effecting an increase in the amount of an endostatin in ocular tissues of an individual afflicted with ocular neovascularization to an ocular neovascularization inhibiting effective amount
12/05/2002	US20020183248 Locally administering to a cutaneous site at least one lectin capable of interfering with the infective capability of a pathogenic microorganism toward dermal tissue, in an amount effective to diminish infective capability microorganism
12/05/2002	US20020182750 Intravascular apparatus method
12/05/2002	US20020182728 Method for transdifferentiation of non pancreatic stem cells to the pancreatic differentiation pathway
12/05/2002	US20020182659 Method to determine TGF-beta
12/05/2002	US20020182643 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell
12/05/2002	US20020182412 In a polymer microparticle in a (water-in-oil)-in-water emulsion-based method, and using a solvent that comprises ethyl acetate.
12/05/2002	US20020182317 Dry-copying method for producing flat, individually dosed preparations of active agents
12/05/2002	US20020182306 Coating system
12/05/2002	US20020182278 Composition containing Asiasari Radix extracts for protecting brain cells and improving memory
12/05/2002	US20020182275 Novel tablets incorporating isoflavone plant extracts and methods of manufacturing them
12/05/2002	US20020182269 Cucumis melo extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance
12/05/2002	US20020182267 Compositions to control oral microbial oxidation-reduction (Eh) levels
12/05/2002	US20020182266 Vitamin C, vitamin E, beta-carotene, zinc and copper, preferably in tablet form
12/05/2002	US20020182265 Lubricious coatings for substrates
12/05/2002	US20020182263 Pharmaceutical composition comprising dimethylsulfoxide and ozone
12/05/2002	US20020182259 Microcrystalline cellulose compressibility augmenting agent which restricts the proximity of the interface between adjacent surfaces; andinhibits interactions between adjacent surfaces
12/05/2002	US20020182258 Microparticles for delivery of nucleic acid
12/05/2002	US20020182256 Novel oral dosage form for carvedilol
12/05/2002	US20020182255 Especially a sustained release composition for the treatment of ocular and periocular infections.
12/05/2002	US20020182254 Biodegradable blend of polycaprolactone and crystallization modifier composed of a crystalline fatty acid or crystalline fatty acid ester of polyhydric alcohol for use in the controlled release of biologically active proteins
12/05/2002	US20020182253 Sustained-release microgranules containing diltiazem as active principle
12/05/2002	US20020182252 Ph-dependent sustained release, drug-delivery composition
12/05/2002	US20020182251 Antibiotic(s) preparation with retarding active ingredient release
12/05/2002	US20020182249 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
12/05/2002	US20020182248 Liposomes and liposomal dispersion
12/05/2002	US20020182247 Patches containing buprenorphine hydrochloride
12/05/2002	US20020182225 Combining the empty liposomes of uniform size with a solution comprising a membrane-bound protein incorporated into liposomes; especially purified or recombinant tissue factor or natural or synthetic phospholipids
12/05/2002	US20020182221 Recombinant papillomavirus vaccine and method for production and treatment
12/05/2002	US20020182190 Microparticle protection of therapeutic agents
12/05/2002	US20020182185 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/05/2002	US20020182155 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
12/05/2002	US20020182146 Preparation of protein microspheres, films and coatings
12/05/2002	US20020180077 Carbon nanotube fiber-reinforced composite structures for EM and lightning strike protection
12/05/2002	US20020179718 Duplicate laser marking discrete consumable articles
12/05/2002	US20020179096 Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
12/05/2002	DE19549645C2 Sugar-free coated products with layers of mixt. of glucopyranosyl-sorbitol and -mannitol derivs. - over core, also the mixt. and other products contg. it, useful in confectionery, baked goods, pharmaceuticals etc.
12/05/2002	DE10221863A1 Phospholipidische Zusammensetzung sowie deren Verwendung Phospholipid composition and use thereof
12/05/2002	DE10126924A1 Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
12/05/2002	DE10126163A1 Solid, semi-solid or liquid pharmaceutical or cosmetic preparations, containing pyrogenic silicon dioxide of high tamped density as auxiliary to provide good flow properties
12/05/2002	DE10124820A1 Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut Composition and use of substances for the stabilization of sulfur-containing amino acids in blood
12/05/2002	DE10118282A1 Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and tackifier resins, for medical uses
12/05/2002	DE10110494C1 Thin wafer manufacture from an active film involves slitting film into long strips which are stacked and smoothed before cross-cutting to length
12/05/2002	CA2614902A1 Metering and packaging of controlled release medication
12/05/2002	CA2614899A1 Metering and packaging of controlled release medication
12/05/2002	CA2459176A1 Oral composition comprising an extract from the bark of albizzia myriophylla
12/05/2002	CA2452154A1 Carbohydrate modifying agent and drinks containing the modifying agent
12/05/2002	CA2449009A1 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
12/05/2002	CA2448997A1 Metering and packaging of controlled release medication
12/05/2002	CA2448753A1 Surface roughness quantification of pharmaceutical, herbal, nutritional dosage forms and cosmetic preparations
12/05/2002	CA2448638A1 Nucleotide compounds that block the bitter taste of oral compositions
12/05/2002	CA2448627A1 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
12/05/2002	CA2448438A1 Soft elastic capsules comprising ritonavir and/or lopinavir
12/05/2002	CA2448363A1 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
12/05/2002	CA2448345A1 Stable liquid formulations of antibodies
12/05/2002	CA2448320A1 Ribozyme based treatment of female reproductive diseases
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2448081A1 Medicinal compositions
12/05/2002	CA2448068A1 Drug preparations
12/05/2002	CA2447693A1 Taste-masking of highly water-soluble drugs
12/05/2002	CA2447562A1 Pirenzepine ophthalmic gel
12/05/2002	CA2445650A1 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/05/2002	CA2441113A1 Embolic devices capable of in-situ reinforcement
12/04/2002	EP1262555A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells
12/04/2002	EP1262490A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF
12/04/2002	EP1262198A1 Composition with sustained release of levodopa and carbidopa
12/04/2002	EP1262192A2 Compositions and methods for human gastrointestinal health
12/04/2002	EP1262186A1 Azalide antibiotic compositions
12/04/2002	EP1262185A1 Synergistic antibiotic compositions
12/04/2002	EP1262184A1 Compositions comprising S-tofisopam and use of these compositions for the preparation of a medicament for the treatment or prevention of convulsions or seizures
12/04/2002	EP1262177A2 Medical use of thyromimetic compounds to treat hair loss and compositions
12/04/2002	EP1262174A1 Two part hard shell capsule made of poly(1,4-alpha-D-glucane) and starch
12/04/2002	EP1262173A1 Oral intake solution comprising reduced water
12/04/2002	EP1262172A1 Liquid polymer composition for prevention and treatment of the oral cavity diseases
12/04/2002	EP1262163A1 Composition having a liquid fatty phase gelified by a semicrystalline polymer
12/04/2002	EP1262105A1 Phospholipid composition and use thereof
12/04/2002	EP1261691A2 Serum free cultivation of primate embryonic stem cells
12/04/2002	EP1261672A2 Glyceride oil based coating waxes
12/04/2002	EP1261646A1 Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof
12/04/2002	EP1261622A2 Purified lh
12/04/2002	EP1261620A2 Cationic amphiphiles for use in nucleic acid transfection
12/04/2002	EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
12/04/2002	EP1261598A1 Internal 1,15-lactones of fluprostenol and related prostaglandin f2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
12/04/2002	EP1261470A1 Method and apparatus for blowmolding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules
12/04/2002	EP1261427A2 Microfabricated devices and methods for storage and selective exposure of chemicals

1 ... 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 ... 2991